Editorial Open Access
Volume 1 | Issue 1 | DOI: https://doi.org/10.33696/cancerimmunol.1.002

Chimeric Antigen Receptor CAR NK Cells Emerging Immunotherapy for the Treatment of Cancer

  • 1Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA
+ Affiliations - Affiliations

Corresponding Author

Sachin Kumar Deshmukh, skdeshmukh@health.southalabama.edu

Received Date: September 13, 2019

Accepted Date: September 18, 2019


CAR-NK cells, Immunotherapy, NK cells, Chimeric antigen receptor, Novel therapies

Author Information X